Skip to main content
VM

Visby Medical

Visby Medical offers a portable, instrument-free PCR testing platform for rapid, point-of-care infectious disease diagnosis. Their technology delivers accurate results for STIs and respiratory illnesses in under 30 minutes, enabling immediate treatment decisions and improving patient outcomes.

San Jose, United StatesFounded 201219510K+ followers
Updated 3 months ago

Funding

$55M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

+1
Funding rounds are not available yet.

Founders

Product

Problem

The traditional process for diagnosing infectious diseases, particularly STIs and respiratory illnesses, often involves lengthy turnaround times for laboratory results. This delay can lead to delayed treatment, increased patient anxiety, and potential for disease transmission.

Solution

Visby Medical provides a portable, instrument-free PCR testing platform designed for point-of-care use. This technology enables healthcare providers to obtain accurate diagnostic results for infectious diseases within 30 minutes, directly during a patient visit. By delivering rapid results, Visby Medical facilitates the "Test, Talk, and Treat" paradigm, allowing for immediate, data-driven treatment decisions and improving patient outcomes. The platform aims to make advanced molecular diagnostics accessible and efficient in various clinical settings.

Target Audience

The primary target audience includes healthcare providers such as physicians, urgent care clinics, and diagnostic laboratories seeking rapid, accurate, and convenient infectious disease testing solutions.

Features

  • Portable, instrument-free PCR diagnostic device for infectious disease testing.
  • Delivers results in under 30 minutes at the point of care.
  • Utilizes true PCR technology for high sensitivity and specificity.
  • Available for Sexual Health (detecting Chlamydia, Gonorrhea, Trichomoniasis) and Respiratory Health (detecting Flu A, Flu B, and SARS-CoV-2).
  • CLIA-waived for use in physician offices, urgent care centers, and other point-of-care settings.
  • Single-use, disposable design eliminates the need for maintenance or calibration.
  • Facilitates same-visit diagnosis and treatment, improving antibiotic stewardship.
  • Supports self-collected vaginal swabs for women's sexual health testing.
  • Offers anterior nasal and nasopharyngeal specimen collection options for respiratory testing.
This profile is AI-generated and may contain inaccuracies.